|By PR Newswire||
|March 10, 2014 02:29 PM EDT||
LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
This research service provides a list of key technology trends in health and wellness that are likely to have an impact in the year 2013 until 2017. The slides provide a brief snapshot of the technology, the key benefits or strengths, trends and initiatives, key stakeholders and their solutions, applications, enabling technologies, insights and recommendations as applicable for the identified list of technologies.
Research Scope and Index
Top Technology Trends:
Targeted Drug Delivery
Recombinant Expression Systems
Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2013.
The slides provide information on the following lines on a best effort basis, as applicable to the technology under consideration.
They are as follows:
• Brief Snapshot of the Technology
• Recent Developments
• Key Stakeholders and their Solutions
• Future Scenario
•Strategic Decision Makers
•Technology Policy Heads
•Market Research Reports
•Technology Policy information Sites
•Thought Leader Briefings
Personalized medicine involves the study of human diseases at molecular level, pairing the advances in molecular diagnostics, along with genomics based drug development. Particular treatment design according to the individual's genome and epigenome is the goal.
As the aging population grows and seeks more services for disease screening, diagnosis and monitoring, the demand for novel life sciences tools increases.
•Personalized medicine (PM) aims to characterize disease at different levels and evolution stages to target specific genes or molecular pathways.
•Miniaturized, wireless, implantable sensors, are finding increased opportunities to more conveniently provide real-time information about a patient's condition.
•Omics-based technologies have revolutionized life sciences research and biomedical engineering, by generating huge amounts of information.
•Important efforts are being conducted toward becoming this information in valuable insights for clinical and biomedical routine tools for early diagnostics and prognostics.
Year of Impact
•Personalized medicine involves an evolving challenge from part of a broad spectrum of fields of research covering both sciences traditionally contributing to medicine and healthcare advances, such as genetics, biology, and pharmacology, and their -omics related fields, that is, proteomics, transcriptomics, metabonomics, and so on.
•More recently contributing sciences, such as bioinformatics, robotics, nanobiotechnology, mechatronics, and biomics, also play a critical role in the impact of personalized medicine in the human health.
•A solid convergence of these technologies is expected by 2016 for commercialization and 2018 for wide scale adoption.
•Personalized medicine (PM) deeply digs inside the study of human diseases at molecular level, pairing the advances in molecular diagnostics, as well as, genomics based drug development. The aim of PM is to harmonize the relation between treatment and patient, taking into consideration the individual variations that lead to a specific behavior and drug response, could even involve the particular treatment design according to the individual genotype among other features.
•Toward this concept, coined terms as stratified medicine and integrated healthcare attempt to cover developments in genomics-based personalized medicines for different clusters, predisposition testing, preventive medicine, combination of diagnostics with therapeutics, and monitoring of therapy.
•A new vision attempting to avoid costly and prolonged trial and error approaches, while precluding treatment side effects, in conjunction with significant gain time, is being achieved.
•Personalized diagnostics and therapeutics
•Response drug evaluation and screening for new, more specific molecular entities
•Facing rare disease challenges for novel solutions
•Addressing autoimmune and inflammatory diseases therapies
•Attrition rate, risk, cost and time reduction
•Use of virtual clinical trials and more caution experimental design for stratified groups
•Holistic view of human health
•New niches for molecular entities
Technology Roadmap (2000-2020)
1. Stratified Medicine
Gene expression/disease correlation
Pathways modeling/simulation and biomarkers development
Focus on cancer research
In silico, in vitro, in vivo models for experimental design and clinical trials
2. Personalized Theranostics
Single molecule biosensors
Systems biology/Modeling and simulation
Micro/nanotech for cancer/infectious diseases diagnostics
Flexible assay platform (platform independence)
Multipanel biomarker assays
3. Virtual Patients
Virtual populations for clinical trials
Disease prediction and risk management
Targeted tumor therapeutics
Epigenome-based tech platforms
In silico early diagnostic tests
Pathway regulation therapeutics
Circulating customized microvesicle-based cancer testing
Technology Development and Adoption Footprint
Pioneering in PM, the US possess one of the strongest R&D networks, counting with solid and well established public and private funding sources
The EU is remarkable promoting the advancement of PM approaches through its numerous FP7 programmes. In turn, national ecosystems are also emerging
Japan, India and Australia lead the development of PM, not only in a direct manner, but also promoting the development of enabling cutting-edge technologies
Marshfield Clinic, Wisconsin, US: Establishment of the Center for Medical Genetics, Personalized Medicine Research Center, Personalized Medicine Research Project (PMRP), Wisconsin Genomics Initiative (WGI). University of California San Francisco (UCSF), US: Collaboration line with Kaiser Permanente (an insurance company) to expand its existing data bank of clinical information to include genetic sequencing information. Launch of the Research Program on Genes, Environment and Health (RPGEH) initiative, and the Pharmacogenomics Research Network'(PGRN). University of Chicago, US: Launch of the 1200 Patients Project to pave the way for introducing the PM approach in the clinical routine. Mayo Clinic;, US: Creation of the Center for Individualized Medicine, with its Translational and Infrastructure programmes. Etc.
Indiana Center for Systems Biology and Personalized Medicine, Center for Integration of Medicine & Innovative Technology (CIMIT)-Massachusetts General Hospital (MGH), Integrated Biobank of Luxembourg (IBBL), Fraunhofer Institute for Systems and Innovation Research, Institut national de la santé et de la recherche médicale (Inserm), The Institute for Personalized Respiratory Medicine of the University of Illinois Hospital and Health Sciences System, Interuniversity Microelectronics Centre(IMEC), etc.
Affymetrix, Cynvenio, DNA Genotek, Genia, Illumina, Life Technologies, Amgen, Astellas, BI, BMS, Eli Lilly, EMD Serono, Endo Health Solutions, GE, GSK, J&J, Merck, Millennium, Novartis, Pfizer, Atossa Genetics, Fluxion, Nodality, 23andMe, Cureline, Genophen, iSpecimen, N-of-One, Selventa, Kinemed, etc.
Government Agencies/Funding Bodies
Agencies financially supporting PM projects: The Biomedical Information Science and Technology Initiative (NIH/BISTI), National Institute of General Medical Sciences (NIH/NIGMS), Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS), Small Business Innovation Research (SBIR), Small Business Technology Transfer Program (STTR), European Commission (EU), European Research Council (ERC), European Science Foundation (ESF), European Association for Predictive, Preventive and Personalised Medicine (EPMA), European Organisation of Personalised Medicine (EPEMED), Asia-Pacific Economic Cooperation (APEC), which through their multiple framework programmes hold strong focus on PM envisioning 2020. VCs: Burrill & Company, Kleiner Perkins Caufield & Byers, Mohr Davidow, Pappas Ventures, Third Rock Ventures, LLC
Regulators/ Associations/Standardization Bodies
FDA and EMA have issued draft guidelines on registration and approval procedures regarding patient populations stratification to facilitate targeted therapy.
Table of Contents
Executive Summary 3
Personalized Medicine 6
Targeted Drug Delivery 16
Regenerative Medicine 26
Next-Generation Prebiotics 46
Nutrient Encapsulation 51
Nanoparticle-based Therapies 56
Next-Generation Sequencing 66
Recombinant Expression Systems 72
The Frost & Sullivan Story 77
Read the full report:
Top Technologies in Health and Wellness
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo, November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Learn what is going on, contribute to the discussions, and e...
Sep. 4, 2015 02:00 PM EDT Reads: 216
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
Sep. 4, 2015 02:00 PM EDT Reads: 264
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
Sep. 4, 2015 01:45 PM EDT Reads: 647
The Internet of Things is in the early stages of mainstream deployment but it promises to unlock value and rapidly transform how organizations manage, operationalize, and monetize their assets. IoT is a complex structure of hardware, sensors, applications, analytics and devices that need to be able to communicate geographically and across all functions. Once the data is collected from numerous endpoints, the challenge then becomes converting it into actionable insight.
Sep. 4, 2015 12:30 PM EDT Reads: 121
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
Sep. 4, 2015 12:00 PM EDT Reads: 296
With the Apple Watch making its way onto wrists all over the world, it’s only a matter of time before it becomes a staple in the workplace. In fact, Forrester reported that 68 percent of technology and business decision-makers characterize wearables as a top priority for 2015. Recognizing their business value early on, FinancialForce.com was the first to bring ERP to wearables, helping streamline communication across front and back office functions. In his session at @ThingsExpo, Kevin Roberts...
Sep. 4, 2015 12:00 PM EDT Reads: 110
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
Sep. 4, 2015 12:00 PM EDT Reads: 502
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
Sep. 4, 2015 11:45 AM EDT Reads: 401
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
Sep. 4, 2015 11:45 AM EDT Reads: 585
17th Cloud Expo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises ar...
Sep. 4, 2015 11:00 AM EDT Reads: 1,617
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
Sep. 4, 2015 11:00 AM EDT Reads: 250
In 2014, the market witnessed a massive migration to the cloud as enterprises finally overcame their fears of the cloud’s viability, security, etc. Over the past 18 months, AWS, Google and Microsoft have waged an ongoing battle through a wave of price cuts and new features. For IT executives, sorting through all the noise to make the best cloud investment decisions has become daunting. Enterprises can and are moving away from a "one size fits all" cloud approach. The new competitive field has ...
Sep. 4, 2015 11:00 AM EDT Reads: 192
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
Sep. 4, 2015 11:00 AM EDT Reads: 429
SYS-CON Events announced today that the "Second Containers & Microservices Expo" will take place November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities.
Sep. 4, 2015 10:45 AM EDT Reads: 663
Moving an existing on-premise infrastructure into the cloud can be a complex and daunting proposition. It is critical to understand the benefits as well as the challenges associated with either a full or hybrid approach. In his session at 17th Cloud Expo, Richard Weiss, Principal Consultant at Pythian, will present a roadmap that can be leveraged by any organization to plan, analyze, evaluate and execute on a cloud migration solution. He will review the five major cloud transformation phases a...
Sep. 4, 2015 10:15 AM EDT Reads: 129